What was the overall market valuation for the Germany chorea market in 2024?

The overall market valuation for the Germany chorea market was $44.0 Million in 2024. Read More

What is the projected market valuation for the Germany chorea market by 2035?

The projected market valuation for the Germany chorea market is $86.5 Million by 2035. Read More

What is the expected CAGR for the Germany chorea market during the forecast period 2025 - 2035?

The expected CAGR for the Germany chorea market during the forecast period 2025 - 2035 is 6.34%. Read More

What are the market segments for the Germany chorea market based on type?

The market segments based on type include Huntington's disease ($20.0 - $40.0 Million), Rheumatic (Sydenham's Chorea) ($15.0 - $30.0 Million), and Drug-induced Chorea ($9.0 - $16.5 Million). Read More

What are the treatment segments in the Germany chorea market?

The treatment segments in the Germany chorea market are Medical care ($26.0 - $54.0 Million) and Surgical care ($18.0 - $32.5 Million). Read More

How is the distribution channel structured in the Germany chorea market?

The distribution channels include Hospitals ($8.8 - $17.5 Million), Clinics ($6.6 - $13.2 Million), Diagnostic centers ($5.5 - $11.0 Million), Drug stores ($7.0 - $14.0 Million), and Pharmacies ($10.5 - $21.0 Million). Read More

What symptoms are associated with the Germany chorea market?

Symptoms associated with the Germany chorea market include Involuntary muscle movements ($10.0 - $20.0 Million), Milkmaid's grip ($8.0 - $15.0 Million), Speech problems ($12.0 - $25.0 Million), and Seizures ($14.0 - $26.5 Million). Read More

What are the end-user segments in the Germany chorea market?

End-user segments in the Germany chorea market include Clinics ($8.8 - $17.5 Million), Hospitals ($15.0 - $30.0 Million), Ambulatory surgical centers ($10.0 - $20.0 Million), and Others ($10.2 - $19.0 Million). Read More

What trends are expected in the Germany chorea market by 2035?

Trends expected in the Germany chorea market by 2035 include increased market valuation and growth driven by advancements in treatment options and rising awareness of chorea symptoms. Read More

Germany Chorea Market

Q: Which companies are considered key players in the Germany chorea market?

Key players in the Germany chorea market include Teva Pharmaceutical Industries Ltd, Bristol-Myers Squibb Company, Novartis AG, AbbVie Inc, Roche Holding AG, Pfizer Inc, Eli Lilly and Company, and AstraZeneca PLC. Read More

ID: MRFR/MED/51940-HCR

200 Pages

Vikita Thakur

Last Updated: February 06, 2026

Germany Chorea Market Research Report By Distribution Channel (hospitals, clinics, diagnostic centers, drug stores, pharmacies, others), By Symptoms (involuntary muscle movements, milkmaid's grip, speech problems, seizures), By End User (clinics, hospitals, ambulatory surgical centers, others), By Product Type (Medication, Surgery therapy) and By Treatment (Medical care, Surgical care) - Growth & Industry Forecast 2025 To 2035

Germany Chorea Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)6.34%

2024 Market Size$ 44 Million

2025 Market Size$ 46.79 Million

2035 Market Size$ 86.5 Million

Key Players

Teva Pharmaceutical Industries Ltd

Bristol-Myers Squibb Company

Novartis AG

AbbVie Inc

Roche Holding AG

Pfizer Inc

Trends

Rising Awareness and Education
Advancements in Treatment Options
Integration of Technology in Care

Opportunities

Government Initiatives and Funding
Emerging Biopharmaceutical Innovations
Growing Demand for Personalized Medicine

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Industrial Automation & Equipment, BY Type (USD Million)
  1. 4.1.1 Huntington's disease
  2. 4.1.2 Rheumatic (Sydenham's Chorea)
  3. 4.1.3 Drug-induced Chorea
2. 4.2 Industrial Automation & Equipment, BY Treatment (USD Million)
  1. 4.2.1 Medical care
  2. 4.2.2 Surgical care
3. 4.3 Industrial Automation & Equipment, BY Distribution Channel (USD Million)
  1. 4.3.1 Hospitals
  2. 4.3.2 Clinics
  3. 4.3.3 Diagnostic centers
  4. 4.3.4 Drug stores
  5. 4.3.5 Pharmacies
  6. 4.3.6 Others
4. 4.4 Industrial Automation & Equipment, BY Symptoms (USD Million)
  1. 4.4.1 Involuntary muscle movements
  2. 4.4.2 Milkmaid's grip
  3. 4.4.3 Speech problems
  4. 4.4.4 Seizures
5. 4.5 Industrial Automation & Equipment, BY End-Users (USD Million)
  1. 4.5.1 Clinics
  2. 4.5.2 Hospitals
  3. 4.5.3 Ambulatory surgical centers
  4. 4.5.4 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Industrial Automation & Equipment
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Industrial Automation & Equipment
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Teva Pharmaceutical Industries Ltd (IL)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Bristol-Myers Squibb Company (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Novartis AG (CH)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 AbbVie Inc (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Roche Holding AG (CH)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Pfizer Inc (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Eli Lilly and Company (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 AstraZeneca PLC (GB)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 GERMANY MARKET ANALYSIS BY TYPE
3. 6.3 GERMANY MARKET ANALYSIS BY TREATMENT
4. 6.4 GERMANY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
5. 6.5 GERMANY MARKET ANALYSIS BY SYMPTOMS
6. 6.6 GERMANY MARKET ANALYSIS BY END-USERS
7. 6.7 KEY BUYING CRITERIA OF INDUSTRIAL AUTOMATION & EQUIPMENT
8. 6.8 RESEARCH PROCESS OF MRFR
9. 6.9 DRO ANALYSIS OF INDUSTRIAL AUTOMATION & EQUIPMENT
10. 6.10 DRIVERS IMPACT ANALYSIS: INDUSTRIAL AUTOMATION & EQUIPMENT
11. 6.11 RESTRAINTS IMPACT ANALYSIS: INDUSTRIAL AUTOMATION & EQUIPMENT
12. 6.12 SUPPLY / VALUE CHAIN: INDUSTRIAL AUTOMATION & EQUIPMENT
13. 6.13 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TYPE, 2024 (% SHARE)
14. 6.14 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TYPE, 2024 TO 2035 (USD Million)
15. 6.15 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TREATMENT, 2024 (% SHARE)
16. 6.16 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TREATMENT, 2024 TO 2035 (USD Million)
17. 6.17 INDUSTRIAL AUTOMATION & EQUIPMENT, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
18. 6.18 INDUSTRIAL AUTOMATION & EQUIPMENT, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
19. 6.19 INDUSTRIAL AUTOMATION & EQUIPMENT, BY SYMPTOMS, 2024 (% SHARE)
20. 6.20 INDUSTRIAL AUTOMATION & EQUIPMENT, BY SYMPTOMS, 2024 TO 2035 (USD Million)
21. 6.21 INDUSTRIAL AUTOMATION & EQUIPMENT, BY END-USERS, 2024 (% SHARE)
22. 6.22 INDUSTRIAL AUTOMATION & EQUIPMENT, BY END-USERS, 2024 TO 2035 (USD Million)
23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY TREATMENT, 2025-2035 (USD Million)
  3. 7.2.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
  4. 7.2.4 BY SYMPTOMS, 2025-2035 (USD Million)
  5. 7.2.5 BY END-USERS, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

Germany Industrial Automation & Equipment Market Segmentation

Industrial Automation & Equipment By Type (USD Million, 2025-2035)

Huntington's disease
Rheumatic (Sydenham's Chorea)
Drug-induced Chorea

Industrial Automation & Equipment By Treatment (USD Million, 2025-2035)

Medical care
Surgical care

Industrial Automation & Equipment By Distribution Channel (USD Million, 2025-2035)

Hospitals
Clinics
Diagnostic centers
Drug stores
Pharmacies
Others

Industrial Automation & Equipment By Symptoms (USD Million, 2025-2035)

Involuntary muscle movements
Milkmaid's grip
Speech problems
Seizures

Industrial Automation & Equipment By End-Users (USD Million, 2025-2035)

Clinics
Hospitals
Ambulatory surgical centers
Others

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”